학술논문
Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes.
Document Type
Article
Author
Source
Therapeutic Advances in Hematology; Jan-Dec2021, Vol. 12, p1-11, 11p
Subject
Language
ISSN
20406207